Research letters: Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation

AIDS

Volumn 28, Issue 18, 2014, Pages 2781-2786

  Parsons, Matthew S ^a   Loh, Liyen ^a   Gooneratne, Shayarana ^a   Center, Rob J ^a,b   Kent, Stephen J ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BURNET INSTITUTE   (Australia)

^c MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CELL DIFFERENTIATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE EDUCATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

HIV ANTIBODIES; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION;

EID: 84927704125     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000489     Document Type: Article

References (15)

1. Chung AW, Rollman E, Center RJ, Kent SJ, Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol 2009; 182:1202-1210.
2. Smalls-Mantey A, Doria-Rose N, Klein R, Patamawenu A, Migueles SA, Ko SY, et al. Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4R T cells is directly associated with the magnitude of surface IgG binding. J Virol 2012; 86:8672-8680.
3. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012; 366:1275-1286.
4. Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, et al. Heterogeneous neutralizing antibody and antibodydependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 2009; 23:897-906.
5. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25:331-342.
6. Parsons MS, Wren L, Isitman G, Navis M, Stratov I, Bernard NF, Kent SJ. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J Virol 2012; 86:4488-4495.
7. Parsons MS, Zipperlen K, Gallant M, Grant M. Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells. J Leukoc Biol 2010; 88:905-912.
8. Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, et al. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 2012; 122:3260-3270.
9. Wren LH, Stratov I, Kent SJ, Parsons MS. Obstacles to ideal anti- HIV antibody-dependent cellular cytotoxicity responses. Vaccine 2013; 31:5506-5517.
10. Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 2012; 24:331-341.
11. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16RNK-cell subset. Blood 2010; 116:3865-3874.
12. Parsons MS, Tang CC, Jegaskanda S, Center RJ, Brooks AG, Stratov I, Kent SJ. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression. J Immunol 2014; 192:308- 315.
13. Center RJ, Wheatley AK, Campbell SM, Gaeguta AJ, Peut V, Alcantara S, et al. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens. Vaccine 2009; 27:6605-6612.
14. Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ballmaier M, Bhatnagar N, et al. HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16R NK cells. J Virol 2010; 84:1183-1188.
15. Liu Q, Sun Y, Rihn S, Nolting A, Tsoukas PN, Jost S, et al. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J Virol 2009; 83:8705-8712.